Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Camino Neurocare is a medical technology company specializing in neurocritical care, specifically known for its pioneering intracranial pressure (ICP) monitoring systems. The company's core technology involves fiber-optic catheters that provide precise, real-time measurements of ICP and intracranial temperature without the need for fluid-filled systems. Its flagship Camino ICP Monitor is widely utilized in intensive care units and neurosurgery departments to manage patients with traumatic brain injuries and hemorrhages. After being part of Integra LifeSciences, the Camino product line and associated assets were acquired by Natus Medical in 2017, where it continues to be a leading brand in the neuro-monitoring market. The technology is renowned for its accuracy and ease of use, helping clinicians make life-saving decisions in critical care environments. Today, the Camino portfolio includes a variety of bolted and tunneled catheters designed for both monitoring and cerebrospinal fluid drainage.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Camino Neurocare.